CD274 and neoplasm: Immunotherapy-based treatments can induce immune-mediated changes in the tumor microenvironment, especially in PD-L1 positive tumors, creating an inflamed phenotype characterized by increased immune cell infiltration and subsequently enhanced PD-L1 expression.